Stay updated on Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.5.4, replacing the previous v3.5.3. This signals a minor version update to the page rather than a substantive change to content.
    Difference
    0.0%
    Check dated 2026-05-15T04:15:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3 on the page, indicating a new build of the page’s metadata. The update does not alter the study details or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T17:17:14.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:58:26.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added revision tag v3.5.0 and removed revision tag v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:28:44.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible content changes are indicated.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:48.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added Gastric Cancer to the related topics section and included Genetic and Rare Diseases Information Center as a resources reference.
    Difference
    0.1%
    Check dated 2026-02-18T09:04:18.000Z thumbnail image

Stay in the know with updates to Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.